Shandong Xinhua Pharmaceutical Co Ltd (000756) — Cash Flow Quality Index
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Cash Flow Quality Index of 0.46x as of September 2023. Operating cash flow of CN¥56.11 Million is below net income of CN¥122.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Shandong Xinhua Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Shandong Xinhua Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Xinhua Pharmaceutical Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year earnings quality comparison for Shandong Xinhua Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Shandong Xinhua Pharmaceutical Co Ltd (000756) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.78x | CN¥367.61 Million | CN¥470.02 Million | ▲ +46.4% |
| 2023 | 0.53x | CN¥265.28 Million | CN¥496.51 Million | ▼ -71.0% |
| 2022 | 1.84x | CN¥758.24 Million | CN¥411.19 Million | ▲ +148.0% |
| 2021 | 0.74x | CN¥259.12 Million | CN¥348.55 Million | ▼ -42.5% |
| 2020 | 1.29x | CN¥420.19 Million | CN¥324.86 Million | ▲ +11.4% |
| 2019 | 1.16x | CN¥348.27 Million | CN¥299.97 Million | ▼ -8.5% |
| 2018 | 1.27x | CN¥323.91 Million | CN¥255.31 Million | ▼ -31.8% |
| 2017 | 1.86x | CN¥389.97 Million | CN¥209.59 Million | ▼ -48.2% |
| 2016 | 3.59x | CN¥439.35 Million | CN¥122.27 Million | ▼ -14.4% |
| 2015 | 4.20x | CN¥348.64 Million | CN¥83.06 Million | — |